How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/prevention-of-covid-19-in-individuals-6-months-through-4-years-of-age-with-certain-health-conditions.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Prevention of COVID-19 in individuals 6 months through 4 years of age with certain health conditions — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevention of COVID-19 in individuals 6 months through 4 years of age with certain health conditions (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevention of COVID-19 in individuals 6 months through 4 years of age with certain health conditions, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Investigational COVID-19 Vaccine	Investigational COVID-19 Vaccine	BioNTech	Not specified	Not specified
BNT162b2 (Omi KP.2)	bnt162b2-omi-kp-2	Pfizer Inc.	mRNA vaccine	Spike protein of SARS-CoV-2

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

BioNTech · 1 drug in Prevention of COVID-19 in individuals 6 months through 4 years of age with certain health conditions
Pfizer Inc. · 1 drug in Prevention of COVID-19 in individuals 6 months through 4 years of age with certain health conditions

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevention of COVID-19 in individuals 6 months through 4 years of age with certain health conditions:

Cite this brief

Drug Landscape (2026). Prevention of COVID-19 in individuals 6 months through 4 years of age with certain health conditions — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-covid-19-in-individuals-6-months-through-4-years-of-age-with-certain-health-conditions. Accessed 2026-06-10.

Prevention of COVID-19 in individuals 6 months through 4 years of age with certain health conditions full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing